SCHEMBL3389488

SCHEMBL3389488

CCN(CC)c1cccc(C(=O)O)c1C(=O)c1ccccc1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.52
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALDH1A1 P00352 8/20 0.47
KDM4E B2RXH2 4/20 0.47
HPGD P15428 4/20 0.47
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA7 P43166 2/20 0.47
CA9 Q16790 2/20 0.47
CA14 Q9ULX7 2/20 0.47
HMGB1 P09429 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
NAPRT Q6XQN6 1/20 0.47
GAA P10253 2/20 0.42
POLB P06746 1/20 0.42
G6PD P11413 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30026207 1.00 SMN1; SMN2 (0.52) SMN1; SMN2KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL28239485 0.89 LIG1 (0.46) SMN1; SMN2KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL28076225 0.87 AKR1C3 (0.49) SMN1; SMN2KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL27985312 0.87 MEN1 (0.51) SMN1; SMN2KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL22939654 0.85 MEN1 (0.52) SMN1; SMN2KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL28371258 0.84 CA12 (0.51) SMN1; SMN2KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL11225789 0.82 SMN1; SMN2 (0.52) SMN1; SMN2KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL22939033 0.81 SMN1; SMN2 (0.56) SMN1; SMN2KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL22939525 0.80 SMN1; SMN2 (0.49) SMN1; SMN2KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL28358177 0.79 KMT2A (0.58) SMN1; SMN2KMT2AMEN1L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121570375-A Application of DHHB-producing microorganism in daily chemical products 江南大学 2026-02-27 CN claimed
EP-1728816-B1 Method of activating the shrink characteristic of a film CRYOVAC INC (US) 2010-12-22 EP claimed
CN-121570375-A Application of DHHB-producing microorganism in daily chemical products 江南大学 2026-02-27 CN disclosed
EP-4540223-A1 METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE BASF SE (DE) 2025-04-23 EP disclosed
US-20240025841-A1 METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE BASF SE (DE) 2024-01-25 US disclosed
WO-2023242181-A1 METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE BASF SE (DE) 2023-12-21 WO disclosed
EP-4263490-A1 METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE BASF SE (DE) 2023-10-25 EP disclosed
CN-116096701-A Process for obtaining crystalline diethylamino hydroxybenzoyl hexyl benzoate 巴斯夫欧洲公司 2023-05-09 CN disclosed
WO-2022129284-A1 METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE BASF SE (DE) 2022-06-23 WO disclosed
EP-2841488-B1 LIQUID ARYL GROUP-CONTAINING POLYORGANOSILOXANE DOW CORNING TORAY CO LTD (JP) 2019-07-17 EP disclosed
US-9415001-B2 Liquid aryl group-containing polyorganosiloxane DOW CORNING TORAY CO., LTD. (JP) 2016-08-16 US disclosed
US-20150164774-A1 Liquid Aryl Group-Containing Polyorganosiloxane DOW TORAY CO., LTD. (JP) 2015-06-18 US disclosed
EP-2841488-A1 LIQUID ARYL GROUP-CONTAINING POLYORGANOSILOXANE Dow Corning Toray Co., Ltd. (JP) 2015-03-04 EP disclosed
WO-2013161429-A1 LIQUID ARYL GROUP-CONTAINING POLYORGANOSILOXANE DOW CORNING TORAY CO., LTD. (JP) 2013-10-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150164774-A1 Liquid Aryl Group-Containing Polyorganosiloxane RPS3, ALOX12, MSI2 SMN1; SMN2 992/4885KMT2A 2882/4885MEN1 2410/4885
US-20240025841-A1 METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE HDHD5, APEH, ABHD6 SMN1; SMN2 4504/4885KMT2A 2700/4885MEN1 4641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.